Abstract: A method for reading at least one attribute stored in an ID token using first, second and third computer systems, wherein the third computer system comprises a browser and a client, and wherein a service certificate is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user, a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate, the first certificate is stored by the third computer system, the third computer system receives a signed attribute specification via the first connection, a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the first computer system, wherein the third computer system receives a second certificate, the signed attribute specification i

Abstract: A method for reading at least one attribute stored in an ID token using first, second and third computer systems, wherein the third computer system comprises a browser and a client, and wherein a service certificate is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user,: a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate, the first certificate is stored by the third computer system, the third computer system receives a signed attribute specification via the first connection, a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the first computer system, wherein the third computer system receives a second certificate, the signed attribute specification

Abstract: The invention relates to a method for reading at least one attribute stored in an ID token (106, 106?) using first (136), second (150) and third (100) computer systems, wherein the third computer system comprises a browser (112) and a client (113), and wherein a service certificate (144) is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user (102), having the following steps: —a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate (176), —the first certificate is stored by the third computer system, —the third computer system receives a signed attribute specification (182) via the first connection, —a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the f

Abstract: The invention relates to a method for reading at least one attribute stored in an ID token (106, 106?) using first (136), second (150) and third (100) computer systems, wherein the third computer system comprises a browser (112) and a client (113), and wherein a service certificate (144) is assigned to the second computer system, wherein the service certificate comprises an identifier which is used to identify the second computer system, wherein the ID token is assigned to a user (102), having the following steps: a first cryptographically protected connection (TLS1) is set up between the browser of the third computer system and the second computer system, wherein the third computer system receives a first certificate (176), the first certificate is stored by the third computer system, the third computer system receives a signed attribute specification (182) via the first connection, a second cryptographically protected connection (TLS2) is set up between the browser of the third computer system and the first

Abstract: The invention relates to a process for preparing the compound of formula 1 a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.

Abstract: The invention relates to a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterized in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) i) the product thus obtained is hydrogenated and ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand; as well as a process for preparing a salt of an optionally substituted 4-(benzimidazol-2-ylmethylamino)-benzamidine, wherein (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) the product thus obtained is hydrogenated, and (c) i) optionally the amidino group is carbonylated and ii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.

Abstract: The invention relates to a process for preparing the compound of formula 1 a valuable intermediate product in the synthesis of the pharmaceutical active substance dabigatran etexilate.

Abstract: The invention relates to a process for preparing a salt of an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, b) i) the product thus obtained is hydrogenated, ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand and iii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.

Abstract: The invention relates to an electrically conductive foil made of a thermoplastic matrix and conductive reinforcement fibers, wherein the conductive fibers are disposed in the conductive foil in an approximately isotropic manner, and a method for the production thereof.

Abstract: The present invention relates to crystalline polymorphs of 3-O-(3?,3?-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt (“DSB•2NMG)”), pharmaceutical compositions of the same and use of the same as an active pharmaceutical agent in the treatment of HIV related disorders.

Abstract: The invention relates to a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) i) the product thus obtained is hydrogenated and ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand; as well as a process for preparing a salt of an optionally substituted 4-(benzimidazol-2-ylmethylamino)-benzamidine, wherein (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) the product thus obtained is hydrogenated, and (c) i) optionally the amidino group is carbonylated and ii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.

Abstract: A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).

Abstract: The invention relates to a process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) i) the product thus obtained is hydrogenated and ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand; as well as a process for preparing a salt of an optionally substituted 4-(benzimidazol-2-ylmethylamino)-benzamidine, wherein (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, (b) the product thus obtained is hydrogenated, and (c) i) optionally the amidino group is carbonylated and ii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.

Abstract: The invention relates to a process for preparing a salt of an optionally substituted 4-benzimidazol-2-ylmethylamino)-benzamidine, characterised in that (a) an optionally correspondingly substituted diaminobenzene is condensed with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)-phenylamino]-acetic acid, b) i) the product thus obtained is hydrogenated, ii) optionally the amidino group is carbonylated, without isolating the intermediate product of the hydrogenation beforehand and iii) without prior isolation of the intermediate product of the carbonylation the desired salt is isolated.

Abstract: A process for preparing an optionally substituted 4-benzimidazol-2 -ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4 -oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).

Abstract: A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).

Abstract: The present invention relates to crystalline polymorphs of 3-O-(3?,3?-dimethylsuccinyl)betulinic acid di-N-methyl-D-glucamine salt (“DSB•2NMG)”), pharmaceutical compositions of the same and use of the same as an active pharmaceutical agent in the treatment of HIV related disorders.

Abstract: A process for preparing an optionally substituted 4-benzimidazol-2-ylmethylamino)benzamidine, the process comprising: (a) condensing an optionally suitably substituted diaminobenzene with 2-[4-(1,2,4-oxadiazol-5-on-3-yl)phenylamino]acetic acid; (b) hydrogenating the product obtained from step (a); and (c) optionally carboxylating the amidino group of the product obtained from step (b).

Abstract: Disclosed are improved processes for the preparation of a polymorph of 1-[tert-butyl-1-p-tolyl-1H-pyrazol-5-yl]-3-[4-(2-morpolinin-4-yl-ethoxy)naphthalen-1-yl]-urea (1) by crystallization from an alcohol, wherein the improvement is that crude (1) is treated with ethanol.

Abstract: A dissolver for dissolving nuclear fuel materials out of fuel element segments during reprocessing of irradiated nuclear fuels, the dissolver being made of a material which is a neutron absorber and being composed of a dissolving vessel and a dissolving basket disposed in the vessel to receive such fuel element segments and to permit flow of dissolving fluid therethrough, with the basket being divided into a plurality of individual sections or compartments so as to prevent establishment of a critical state in the dissolver.